DELFI blood test identifies lung cancer using artificial intelligence to detect unique patterns in the fragmentation of DNA shed from cancer cells compared to normal profiles. Credit: Carolyn Hruban
A novel artificial intelligence blood testing technology developed by researchers at the Johns Hopkins Kimmel Cancer Center was found to detect over 90% of lung cancers in samples from nearly 800 individuals with and without cancer.
- Read more about Novel AI Blood Testing Technology Can ID Lung Cancers with High Accuracy
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/novel-ai-blood-testing-technology-can-id-lung-cancers-with-high-accuracy
No comments:
Post a Comment